Improving the diagnosis of heart failure in patients with atrial fibrillation

Standard

Improving the diagnosis of heart failure in patients with atrial fibrillation. / Bunting, Karina V; Gill, Simrat K; Sitch, Alice; Mehta, Samir; O'Connor, Kieran; Lip, Gregory Yh; Kirchhof, Paulus; Strauss, Victoria Y; Rahimi, Kazem; Camm, A John; Stanbury, Mary; Griffith, Michael; Townend, Jonathan N; Gkoutos, Georgios V; Karwath, Andreas; Steeds, Richard P; Kotecha, Dipak; RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial group.

In: HEART, Vol. 107, No. 11, 06.2021, p. 902-908.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Bunting, KV, Gill, SK, Sitch, A, Mehta, S, O'Connor, K, Lip, GY, Kirchhof, P, Strauss, VY, Rahimi, K, Camm, AJ, Stanbury, M, Griffith, M, Townend, JN, Gkoutos, GV, Karwath, A, Steeds, RP, Kotecha, D & RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial group 2021, 'Improving the diagnosis of heart failure in patients with atrial fibrillation', HEART, vol. 107, no. 11, pp. 902-908. https://doi.org/10.1136/heartjnl-2020-318557

APA

Bunting, K. V., Gill, S. K., Sitch, A., Mehta, S., O'Connor, K., Lip, G. Y., Kirchhof, P., Strauss, V. Y., Rahimi, K., Camm, A. J., Stanbury, M., Griffith, M., Townend, J. N., Gkoutos, G. V., Karwath, A., Steeds, R. P., Kotecha, D., & RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial group (2021). Improving the diagnosis of heart failure in patients with atrial fibrillation. HEART, 107(11), 902-908. https://doi.org/10.1136/heartjnl-2020-318557

Vancouver

Bunting KV, Gill SK, Sitch A, Mehta S, O'Connor K, Lip GY et al. Improving the diagnosis of heart failure in patients with atrial fibrillation. HEART. 2021 Jun;107(11):902-908. https://doi.org/10.1136/heartjnl-2020-318557

Bibtex

@article{e2544a44d7db49e2949f27817811a09d,
title = "Improving the diagnosis of heart failure in patients with atrial fibrillation",
abstract = "OBJECTIVE: To improve the echocardiographic assessment of heart failure in patients with atrial fibrillation (AF) by comparing conventional averaging of consecutive beats with an index-beat approach, whereby measurements are taken after two cycles with similar R-R interval.METHODS: Transthoracic echocardiography was performed using a standardised and blinded protocol in patients enrolled in the RATE-AF (RAte control Therapy Evaluation in permanent Atrial Fibrillation) randomised trial. We compared reproducibility of the index-beat and conventional consecutive-beat methods to calculate left ventricular ejection fraction (LVEF), global longitudinal strain (GLS) and E/e' (mitral E wave max/average diastolic tissue Doppler velocity), and assessed intraoperator/interoperator variability, time efficiency and validity against natriuretic peptides.RESULTS: 160 patients were included, 46% of whom were women, with a median age of 75 years (IQR 69-82) and a median heart rate of 100 beats per minute (IQR 86-112). The index-beat had the lowest within-beat coefficient of variation for LVEF (32%, vs 51% for 5 consecutive beats and 53% for 10 consecutive beats), GLS (26%, vs 43% and 42%) and E/e' (25%, vs 41% and 41%). Intraoperator (n=50) and interoperator (n=18) reproducibility were both superior for index-beats and this method was quicker to perform (p<0.001): 35.4 s to measure E/e' (95% CI 33.1 to 37.8) compared with 44.7 s for 5-beat (95% CI 41.8 to 47.5) and 98.1 s for 10-beat (95% CI 91.7 to 104.4) analyses. Using a single index-beat did not compromise the association of LVEF, GLS or E/e' with natriuretic peptide levels.CONCLUSIONS: Compared with averaging of multiple beats in patients with AF, the index-beat approach improves reproducibility and saves time without a negative impact on validity, potentially improving the diagnosis and classification of heart failure in patients with AF.",
keywords = "Aged, Aged, 80 and over, Atrial Fibrillation/physiopathology, Biomarkers/blood, Diastole/physiology, Echocardiography, Doppler, Pulsed, Female, Heart Failure/diagnosis, Humans, Male, Natriuretic Peptide, Brain/blood, Peptide Fragments/blood, Reproducibility of Results, Stroke Volume/physiology, Systole/physiology, Ventricular Function, Left/physiology",
author = "Bunting, {Karina V} and Gill, {Simrat K} and Alice Sitch and Samir Mehta and Kieran O'Connor and Lip, {Gregory Yh} and Paulus Kirchhof and Strauss, {Victoria Y} and Kazem Rahimi and Camm, {A John} and Mary Stanbury and Michael Griffith and Townend, {Jonathan N} and Gkoutos, {Georgios V} and Andreas Karwath and Steeds, {Richard P} and Dipak Kotecha and {RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial group}",
note = "{\textcopyright} Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.",
year = "2021",
month = jun,
doi = "10.1136/heartjnl-2020-318557",
language = "English",
volume = "107",
pages = "902--908",
journal = "HEART",
issn = "1355-6037",
publisher = "BMJ PUBLISHING GROUP",
number = "11",

}

RIS

TY - JOUR

T1 - Improving the diagnosis of heart failure in patients with atrial fibrillation

AU - Bunting, Karina V

AU - Gill, Simrat K

AU - Sitch, Alice

AU - Mehta, Samir

AU - O'Connor, Kieran

AU - Lip, Gregory Yh

AU - Kirchhof, Paulus

AU - Strauss, Victoria Y

AU - Rahimi, Kazem

AU - Camm, A John

AU - Stanbury, Mary

AU - Griffith, Michael

AU - Townend, Jonathan N

AU - Gkoutos, Georgios V

AU - Karwath, Andreas

AU - Steeds, Richard P

AU - Kotecha, Dipak

AU - RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial group

N1 - © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

PY - 2021/6

Y1 - 2021/6

N2 - OBJECTIVE: To improve the echocardiographic assessment of heart failure in patients with atrial fibrillation (AF) by comparing conventional averaging of consecutive beats with an index-beat approach, whereby measurements are taken after two cycles with similar R-R interval.METHODS: Transthoracic echocardiography was performed using a standardised and blinded protocol in patients enrolled in the RATE-AF (RAte control Therapy Evaluation in permanent Atrial Fibrillation) randomised trial. We compared reproducibility of the index-beat and conventional consecutive-beat methods to calculate left ventricular ejection fraction (LVEF), global longitudinal strain (GLS) and E/e' (mitral E wave max/average diastolic tissue Doppler velocity), and assessed intraoperator/interoperator variability, time efficiency and validity against natriuretic peptides.RESULTS: 160 patients were included, 46% of whom were women, with a median age of 75 years (IQR 69-82) and a median heart rate of 100 beats per minute (IQR 86-112). The index-beat had the lowest within-beat coefficient of variation for LVEF (32%, vs 51% for 5 consecutive beats and 53% for 10 consecutive beats), GLS (26%, vs 43% and 42%) and E/e' (25%, vs 41% and 41%). Intraoperator (n=50) and interoperator (n=18) reproducibility were both superior for index-beats and this method was quicker to perform (p<0.001): 35.4 s to measure E/e' (95% CI 33.1 to 37.8) compared with 44.7 s for 5-beat (95% CI 41.8 to 47.5) and 98.1 s for 10-beat (95% CI 91.7 to 104.4) analyses. Using a single index-beat did not compromise the association of LVEF, GLS or E/e' with natriuretic peptide levels.CONCLUSIONS: Compared with averaging of multiple beats in patients with AF, the index-beat approach improves reproducibility and saves time without a negative impact on validity, potentially improving the diagnosis and classification of heart failure in patients with AF.

AB - OBJECTIVE: To improve the echocardiographic assessment of heart failure in patients with atrial fibrillation (AF) by comparing conventional averaging of consecutive beats with an index-beat approach, whereby measurements are taken after two cycles with similar R-R interval.METHODS: Transthoracic echocardiography was performed using a standardised and blinded protocol in patients enrolled in the RATE-AF (RAte control Therapy Evaluation in permanent Atrial Fibrillation) randomised trial. We compared reproducibility of the index-beat and conventional consecutive-beat methods to calculate left ventricular ejection fraction (LVEF), global longitudinal strain (GLS) and E/e' (mitral E wave max/average diastolic tissue Doppler velocity), and assessed intraoperator/interoperator variability, time efficiency and validity against natriuretic peptides.RESULTS: 160 patients were included, 46% of whom were women, with a median age of 75 years (IQR 69-82) and a median heart rate of 100 beats per minute (IQR 86-112). The index-beat had the lowest within-beat coefficient of variation for LVEF (32%, vs 51% for 5 consecutive beats and 53% for 10 consecutive beats), GLS (26%, vs 43% and 42%) and E/e' (25%, vs 41% and 41%). Intraoperator (n=50) and interoperator (n=18) reproducibility were both superior for index-beats and this method was quicker to perform (p<0.001): 35.4 s to measure E/e' (95% CI 33.1 to 37.8) compared with 44.7 s for 5-beat (95% CI 41.8 to 47.5) and 98.1 s for 10-beat (95% CI 91.7 to 104.4) analyses. Using a single index-beat did not compromise the association of LVEF, GLS or E/e' with natriuretic peptide levels.CONCLUSIONS: Compared with averaging of multiple beats in patients with AF, the index-beat approach improves reproducibility and saves time without a negative impact on validity, potentially improving the diagnosis and classification of heart failure in patients with AF.

KW - Aged

KW - Aged, 80 and over

KW - Atrial Fibrillation/physiopathology

KW - Biomarkers/blood

KW - Diastole/physiology

KW - Echocardiography, Doppler, Pulsed

KW - Female

KW - Heart Failure/diagnosis

KW - Humans

KW - Male

KW - Natriuretic Peptide, Brain/blood

KW - Peptide Fragments/blood

KW - Reproducibility of Results

KW - Stroke Volume/physiology

KW - Systole/physiology

KW - Ventricular Function, Left/physiology

U2 - 10.1136/heartjnl-2020-318557

DO - 10.1136/heartjnl-2020-318557

M3 - SCORING: Journal article

C2 - 33692093

VL - 107

SP - 902

EP - 908

JO - HEART

JF - HEART

SN - 1355-6037

IS - 11

ER -